 | • レポートコード：MRC2303I0197 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査レポートでは、世界の紫外線殺菌照射市場規模が、予測期間中に年平均8.9%で成長すると予測しています。本書では、紫外線殺菌照射の世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別（空気消毒剤、表面消毒剤、その他）分析、エンドユーザー別（病院・外科センター、研究所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ、アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、その他）分析、競争状況、市場機会・将来の動向など、以下の構成でまとめております。また、American Ultraviolet、Angioscore Ltd、UltraViolet Devices Inc.、Atlantic Ultraviolet Corporation、Ensavior、General Electric （GE Healthcare） 、Koninklijke Philips NV、Halma PLC、Volcano Corporationなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の紫外線殺菌照射市場規模：種類別 - 空気消毒剤の市場規模 - 表面消毒剤の市場規模 - その他種類の市場規模 ・世界の紫外線殺菌照射市場規模：エンドユーザー別 - 病院・外科センターにおける市場規模 - 研究所における市場規模 - その他エンドユーザーにおける市場規模 ・世界の紫外線殺菌照射市場規模：地域別 - 北米の紫外線殺菌照射市場規模 アメリカの紫外線殺菌照射市場規模 カナダの紫外線殺菌照射市場規模 メキシコの紫外線殺菌照射市場規模 … - ヨーロッパの紫外線殺菌照射市場規模 ドイツの紫外線殺菌照射市場規模 イギリスの紫外線殺菌照射市場規模 フランスの紫外線殺菌照射市場規模 … - アジア太平洋の紫外線殺菌照射市場規模 中国の紫外線殺菌照射市場規模 インドの紫外線殺菌照射市場規模 日本の紫外線殺菌照射市場規模 … - 中東・アフリカの紫外線殺菌照射市場規模 GCC諸国の紫外線殺菌照射市場規模 南アフリカの紫外線殺菌照射市場規模 … - 南米の紫外線殺菌照射市場規模 ブラジルの紫外線殺菌照射市場規模 アルゼンチンの紫外線殺菌照射市場規模 … - その他地域の紫外線殺菌照射市場規模 ・競争状況 ・市場機会・将来の動向 |
The ultraviolet germicidal irradiation market is expected to register a CAGR of 8.9% during the forecast period.
The COVID-19 pandemic significantly impacted the growth of the ultraviolet germicidal irradiation market due to the increased demand for disinfection of hospitals and diagnostic laboratories to reduce airborne and surface bacterial and viral infections. For instance, according to an ACS Publications article, innovative disinfection technologies, including UV radiation, were found to be of tremendous importance in preventing the transmission of COVID-19 in 2020. The increased use of UVC sterilization equipment for air and surface disinfection was noticed during the pandemic. Due to the pandemic, healthcare organizations are now more aware of the benefits of ultraviolet germicidal disinfection, which led to increased product launches by major companies globally. For instance, in February 2021, Airific Systems developed UVHeal SafeAir, one of India’s first UVGI systems, tested and certified by the ICMR-CSIR Virology Lab (CCMB) for 99% disinfection against SARS-CoV-2. The key players exhibit a significant interest in producing and launching new practical UVGI products for current and future pandemics, thereby boosting the growth of the market during the forecast period.
In addition, the increasing prevalence of hospital-acquired infections and technological advancements in ultraviolet germicidal irradiation is actively affecting the growth of the market studied.
According to the WHO, out of every 100 patients in acute-care hospitals, seven in wealthy countries and 15 in low- and middle-income countries were likely to acquire at least one healthcare-associated infection (HAI) during their hospital stay in 2022. This increased demand for technologies that effectively eliminate germs and pathogens. The surge in HAI is projected to boost demand for the ultraviolet germicidal irradiation method of disinfection in healthcare institutions, thereby boosting the growth of the market.
Additionally, the advancements in technology and increasing product approvals, along with partnerships and acquisitions by key players, drive the growth of the market. For instance, in January 2022, Iveda launched its commercial-grade, AI-driven ultraviolet germicidal irradiation (UVGI) product. Iveda Smart UVC vents irradiate all kinds of bacteria and viruses, including COVID-19. By leveraging the existing air circulation system, it disinfects the air by irradiating UV light onto the passing air. This eliminates the need to disinfect offices, meeting rooms, and other workspaces manually. As a result, UVGI technologies have undergone technological advancements, leading to the growth of the market.
Therefore, owing to the abovementioned factors, the market studied is anticipated to witness growth over the forecast period. However, limitations associated with ultraviolet germicidal irradiation (UVGI) are likely to impede the growth of the market.
Ultraviolet Germicidal Irradiation Market Trends
The Surface Disinfectant Segment is Expected to Hold a Significant Share During the Forecast Period
Hospital-acquired infections (HAI) are prevalent everywhere, including hospitals and laboratories. Surface disinfectants play a major role in healthcare settings and in common people’s homes to disinfect areas that are most commonly touched to prevent the transmission of infections.
According to the US FDA, consumers were interested in purchasing ultraviolet-C (UVC) lamps to disinfect surfaces in their homes or similar spaces in 2021. Additionally, as per the International Journal of Environmental Research and Public Health article published in 2021, about 50% of hospital-acquired infections occur in the intensive care unit. Surface disinfectants play a crucial role in preventing infections. Hence, the rising burden of HAIs and the benefits of surface disinfectants have resulted in strong demand for and adoption of UV disinfection equipment across healthcare settings, offices, and other workspaces. These factors are expected to propel the growth of the segment during the forecast period.
Furthermore, technological advancements, product launches, approvals, and partnerships among key players, are also expected to drive the growth of the segment. For instance, in July 2020, UV-Concepts Inc., a provider of ultraviolet light disinfection solutions, launched UV-C Enclosure (UVE) worldwide, automated, no-touch UV-C enclosures designed to improve the standard of manual cleaning and disinfection of large portable medical equipment (PME). Such technological advancements and launches are of significant use in healthcare institutions to sterilize the surfaces of medical devices. They are anticipated to boost the utility of surface disinfectants during the forecast period.
North America is Expected to Dominate the Ultraviolet Germicidal Irradiation Market During the Forecast period
North America is expected to dominate the market owing to factors such as the rising incidence of hospital-acquired infections, better healthcare infrastructure, awareness among people and healthcare industry stakeholders about available technologies, and the strong presence of industry players in the region.
Additionally, the rise in chronic diseases like cardiovascular diseases, cancer, and others requires extended hospital stays and surgeries. For instance, according to the AHA, there were approximately 33,356,853 hospital admissions in 2022. Many of these admissions were due to chronic diseases and critical procedures like heart bypass surgery. Thus, the increasing number of hospital admissions is expected to create a need for surface and air disinfection, thereby boosting the market growth in the region.
Furthermore, technological advancements, product launches, and approvals, along with collaborations among key players in the region, are projected to boost the growth of the market. For instance, in January 2022, Steril-Aire, a developer of high-performance indoor air quality (IAQ) and ultraviolet germicidal irradiation (UVGI) technologies, launched their Upper-Air Pro+ using UVGI technology. These devices are designed to quickly disinfect indoor air for airborne infections in locations with dense populations. Such launches are anticipated to boost the growth of the market in the region.
Therefore, owing to the abovementioned factors, the market studied is anticipated to grow in the North American region.
Ultraviolet Germicidal Irradiation Market Competitor Analysis
The ultraviolet germicidal irradiation market is consolidated in nature due to the presence of a few companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Some key players are American Ultraviolet, Angioscore Ltd, UltraViolet Devices Inc., Atlantic Ultraviolet Corporation, Ensavior, General Electric (GE Healthcare), Koninklijke Philips NV, Volcano Corporation, and Halma PLC, among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Hospital-acquired Infection
4.2.2 Technological Advancements in Ultraviolet Germicidal Irradiation
4.3 Market Restraints
4.3.1 Limitations Associated with Ultraviolet Germicidal Irradiation (UVGI)
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size in Value – USD million)
5.1 By Type
5.1.1 Air Disinfectant
5.1.2 Surface Disinfectant
5.1.3 Other Types
5.2 By End User
5.2.1 Hospitals and Surgical Centers
5.2.2 Research Laboratories
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 American Ultraviolet
6.1.2 Angioscore Ltd
6.1.3 UltraViolet Devices Inc.
6.1.4 Atlantic Ultraviolet Corporation
6.1.5 Ensavior
6.1.6 General Electric (GE Healthcare)
6.1.7 Koninklijke Philips NV
6.1.8 Halma PLC
6.1.9 Volcano Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS